Jeffrey P. George's Net Worth
$1.04 Million
Who is Jeffrey P. George?
Jeffrey P. George has an estimated net worth of $1.04 Million. This is based on reported shares across multiple companies, which include Amneal Pharmaceuticals, Inc., and 908 Devices Inc..
SEC CIK
Jeffrey P. George's CIK is 0001796789
Past Insider Trading and Trends
2021 was Jeffrey P. George's most active year for acquiring shares with 6 total transactions. Jeffrey P. George's most active month to acquire stocks was the month of April. 2022 was Jeffrey P. George's most active year for disposing of shares, totalling 3 transactions. Jeffrey P. George's most active month to dispose stocks was the month of April. 2020 saw Jeffrey P. George paying a total of $99,049.60 for 77,550 shares, this is the most they've acquired in one year. In 2023 Jeffrey P. George cashed out on 85,406 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Amneal Pharmaceuticals, Inc. (AMRX) Snapshot price: $5.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +70.94% | 80.13K |
—
|
—
| 193.08K |
May 9 - May 10
| |||
Form 4
| +45.66% | 35.41K |
—
|
—
| 112.96K |
May 8 - May 9
| |||
Form 4
| +147.51% | 46.22K |
—
|
—
| 77.55K |
May 5 - May 6
| |||
Form 4
| +31.59% | 7.52K |
—
|
—
| 31.33K |
Dec 15
| |||
Form 4
|
∞
| 23.81K |
$4.16 | $99,049.60 | 23.81K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
908 Devices Inc. (MASS) Snapshot price: $6.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +7.09% | 508 |
—
|
—
| 7.67K |
Feb 22
| |||
Form 4
| +199.29% | 4.77K |
—
|
—
| 7.17K |
Jun 14 - Jun 15
| |||
Form 4
| +26.87% | 507 |
—
|
—
| 2.39K |
Feb 22
| |||
Form 4
| +271.46% | 1.38K |
—
|
—
| 1.89K |
Jun 15 - Jun 16
| |||
Form 4
|
∞
| 508 |
—
|
—
| 508 |
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LENZ Therapeutics, Inc. (GRPH) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||